Lack of effect of mizolastine on the safety and pharmacokinetics of digoxin administered orally in repeated doses to healthy volunteers

International Journal of Clinical Pharmacology and Therapeutics

Volumn 36, Issue 5, 1998, Pages 286-291

  Chaufour, S ^a   Le Coz, F ^b   Denolle, T ^b   Dubruc, C ^a   Cimarosti, I ^b   Deschamps, C ^a   Ulliac, N ^a   Delhotal Landes, B ^c   Rosenzweig, P ^a  

^a SANOFI   (France)

^b Biotrial   (France)

^c HÔPITAL AMBROISE PARÉ   (France)

Author keywords

Digoxin; Drug interaction; H1 antagonist; Mizolastine; Pharmacokinetics

Indexed keywords

CARDIAC GLYCOSIDE; DIGOXIN; HISTAMINE H1 RECEPTOR ANTAGONIST; MIZOLASTINE;

ADULT; AREA UNDER THE CURVE; ARTICLE; ASTHENIA; CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DIARRHEA; DOUBLE BLIND PROCEDURE; DROWSINESS; DRUG SAFETY; ELECTROCARDIOGRAM; FEVER; HEADACHE; HEMODYNAMICS; HUMAN; HUMAN EXPERIMENT; INFLUENZA; MALE; NAUSEA; NORMAL HUMAN; ORAL DRUG ADMINISTRATION; RANDOMIZED CONTROLLED TRIAL;

ADULT; ANTI-ARRHYTHMIA AGENTS; AREA UNDER CURVE; BENZIMIDAZOLES; BLOOD PRESSURE; CROSS-OVER STUDIES; DIGOXIN; DOUBLE-BLIND METHOD; DRUG INTERACTIONS; ELECTROCARDIOGRAPHY; HISTAMINE H1 ANTAGONISTS; HUMANS; MALE;

EID: 0031981905     PISSN: 09461965     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Arbilla S, Schoemaker H, Scatton B 1990 SL85.0324: a novel benzimidazole derivative with selective histamine H1-receptor antagonist properties. Eur J Clin Pharmacol 183: 218
2. Aronson JK 1983 Digitalis intoxication. Clin Sci 64: 253-258
3. Ascalone V, Guinebault P, Rouchouse A 1993 Determination of mizolastine, a new antihistaminic drug, in human plasma by liquid-liquid extraction, solid-phase extraction, and column-switching techniques in combination with high-performance liquid chromatography. J Chromatogr 619: 275-284
4. Bellioni P, Catalano B, Cervellera G, Filiaci F, Mira E, Carraro A 1996 Comparison of mizolastine with loratadine in the treatment of perennial allergic rhinitis. Rhinology 34: 101-104
5. Belz GG, Wistuba S, Matthews JH 1986 Digoxin and bepridil: pharmacokinetic and pharmacodynamic interactions. Clin Pharmacol Ther 39: 65-71
6. Brostoff J, Fitzharris P, Dunmore C, Theron M, Blondin P 1996 Efficacy of mizolastine, a new antihistamine, compared with placebo in the treatment of chronic idiopathic urticaria. Allergy 51: 320-325
7. Brown DD, Spector R, Juhl RP 1980 Drug interactions with digoxin. Drugs 20: 198-206
8. Cheymol G, Jaillon P 1985 Heterosides cardiotoniques. Sem Hôp Paris 67: 841-873
9. Danjou P, Molinier P, Berlin I, Patat A, Rosenzweig P, Morselli ML 1992 Assessment of the anticholinergic effect of the new antihistamine mizolastine in healthy subject. Br J Clin Pharmacol 34: 328-331
10. Dockens RC, Greene DS, Barbhaiya RH 1996 Assessment of pharmacokinetic and pharmacodynamic drug interactions between nefazodone and digoxin in healthy volunteers. J Clin Pharmacol 36: 160-167
11. Doering W, Maass L, Irmisch R, König E 1987 Pharmacokinetic interaction study with ramipril and digoxin in healthy volunteers. Am J Cardiol 59: 60-64
12. Dubruc C, Duvelleroy A, Bianchetti G, Rosenzweig P, Thénot JP, Morselli PL 1992 Pharmacokinetic profile of mizolastine (SL 85.0324), a new nonsedative H1-antagonist drug, in healthy volunteers (abstract). In: Brès J, Panis G (ed) Pharmacocinétique: de la recherche à la clinique. John Libbey, Montpellier, pp 401-402
13. Lefebvre RA, Bogaert MG, Duprez D 1990 Investigation of possible pharmacokinetic and pharmacodynamic interactions between epanolol and digoxin. Eur J Clin Pharmacol 38: 505-507
14. Leynadier F, Bousquet J, Murrieta P, Attali P 1996 Efficacy and safety of mizolastine in seasonal allergic rhinitis. Ann Allergy Asthma Immunol 76: 163-168
15. Mitchell LB, Jutzy KR, Lewis SJ 1982 Intracardiac electrophysiologic study of intravenous diltiazem and combined diltiazem-digoxin in patients. Am Heart J 103: 57-66
16. Pabst G, Weimann H-J, Weber W 1992 Lack of pharmacokinetic interactions between monoxidine and digoxin. Clin Pharmacokinet 23: 477-481
17. Patat A, Gram LF, Dubruc C, Brohier S, Cabanis MJ, Rosenzweig P 1994 Effects of mizolastine, a new antihistamine, on psychomotor performance and memory in elderly subjects. Int Clin Psychopharmacol 9: 101-108
18. Rodin SM, Johnson BF 1988 Pharmacokinetic interactions with digoxin. Clin Pharmacokinet 15: 227-244
19. Rosenzweig P, Thébault JJ, Caplain H, Dubruc C, Bianchetti G, Fuseau E, Morselli PL 1992 Pharmacodynamics and pharmacokinetics of mizolastine (SL 85.0324), a new nonsedative H1 antihistamine. Ann Allergy 2: 135-139
20. Rosenzweig P, Caplain H, Chaufour S, Ulliac N, Cabanis MJ, Thebault JJ 1995 Comparative wheal and flare study of mizolastine vs terfenadine, cetirizine, loratadine and placebo in healthy volunteers. Br J Clin Pharmacol 40: 459-465
21. Schermann JM 1988 Intérets et limites du dosage des digitaliques. La Lettre du Pharmacologue 4: 97-101
22. Smith TW, Haber E 1973 Digitalis III. N Engl J Med 289: 1063-1072
23. Stern M, Dunmore C, Theron A 1992 A double-blind, placebo-controlled, single-center study of efficacy of mizolastine (SL85.0324) 10 mg once daily in patients suffering from seasonal allergic rhinoconjonctivitis. Allergy 47: 177
24. Sundqvist K, Atterhög J-H, Jogestrand T 1986 Effect of digoxin on the electrocardiogram at rest and during exercise in healthy subjects. Am J Cardiol 57: 661-665
25. Tasman AJ, Weber F 1995 A double-blind, placebo-controlled multicentred study on mizolastine, a new nonsedative H1-repector antagonist in patients suffering from perennial allergic rhinoconjonctivitis. Allergy 26: 79
26. Vuurman EFPM, Uiterwijk MMC, Rosenzweig P, O'Hanlon JF 1994 Effects of mizolastine and clemastine on actual driving and psychomotor performance in healthy volunteers. Eur J Clin Pharmacol 47: 253-259